Clinical Trial Update: OSCAR II STUDY - The ONCObind CTC Removal Study [NA]

View source ↗

Summary

Update on the OSCAR II Study evaluating the ONCObind circulating tumor cell (CTC) removal device; the trial status is not yet recruiting for pancreatic ductal a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: ExThera Medical Corporation | Conditions: Pancreatic Ductal Adenocarcinoma (mPDAC), Metastatic Colorectal Carcinoma (mCRC) | NA | Status: NOT_YET_RECRUITING